EBC Financial Group (Cayman) Limited được cấp Giấy phép hoạt động đầy đủ từ Cơ quan Tiền tệ Quần đảo Cayman (CIMA)
March 28, 2024 06:53 ET
|
EBC Tech Limited
HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC Group hoặc EBC), nhà cung cấp dịch vụ tài chính hàng đầu thế giới, hân hạnh thông báo rằng công ty con tại Quần đảo Cayman, EBC...
EBC Financial Group ได้รับใบอนุญาตอย่างเป็นทางการตามกฎระเบียบเต็มรูปแบบจาก Cayman Financial Regulatory Authority (CIMA)
March 28, 2024 06:53 ET
|
EBC Financial Group
HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) -- EBC Financial Group (Cayman) Limited ได้รับใบอนุญาตด้านกฎระเบียบเต็มรูปแบบอนุมัติโดย Cayman Financial Regulatory Authority (CIMA) โดยมีหมายเลขกำกับดูแล...
EBC Financial Group (Cayman) Limited Mendapatkan Izin Regulasi Penuh dari Otoritas Moneter Kepulauan Cayman (CIMA)
March 28, 2024 06:53 ET
|
EBC Financial Group
HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC Group atau EBC), penyedia layanan keuangan global terkemuka, dengan gembira mengumumkan bahwa anak perusahaan mereka di...
EBC集團獲開曼金融監理局CIMA全監理牌照
March 28, 2024 06:53 ET
|
EBC Financial Group
HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) -- 近日，EBC Financial Group (Cayman) Limited 取得開曼金融監理局CIMA頒發的全監理牌照，監理號2038223。 EBC集團在全球多個重要金融司法轄區取得授權並受其監管，CIMA牌照為EBC集團獲FCA和ASIC牌照後又一里程碑。 ...
EBC集团获开曼金融监管局CIMA全监管牌照
March 28, 2024 06:53 ET
|
EBC Financial Group
HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) -- 近日，EBC Financial Group (Cayman) Limited 获得开曼金融监管局CIMA颁发的全监管牌照，监管号2038223。EBC集团在全球多个重要金融司法辖区获得授权并受其监管，CIMA牌照为EBC集团获FCA和ASIC牌照后又一里程碑。 ...
Rakovina Therapeutics Announces Strategic Pivot to AI
March 27, 2024 16:05 ET
|
Rakovina Therapeutics Inc
Rakovina Therapeutics announces Artificial Intelligence (AI) collaboration
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
March 26, 2024 08:30 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, March 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA
March 26, 2024 07:30 ET
|
Verrica Pharmaceuticals Inc.
NCE status provides a minimum of five years of regulatory exclusivity The Company’s U.S. patents and pending patent applications related to YCANTH™ are projected to expire between 2034 and 2041,...
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
March 22, 2024 07:00 ET
|
Pharmazz, Inc.
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin®) as a resuscitative agent
TDECU and University of Houston Athletics Set New Standard for NIL Agreements and Financial Empowerment for Student Athletes
March 20, 2024 13:47 ET
|
TDECU
Sugar Land, TX, March 20, 2024 (GLOBE NEWSWIRE) -- TDECU, Houston’s largest credit union, and Linking Coogs, the University of Houston’s exclusive Name, Image, and Likeness (NIL) collective, are...